Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood cancer
Pharma
Incyte defends Jakafi against competitor drugs, patent cliff
Jakafi's symptom control and survival benefits will help it remain the leading myelofibrosis drug despite GSK's rival launch, an Incyte exec said.
Angus Liu
Oct 31, 2023 11:23am
PharmaEssentia shares rare blood cancer stories in video series
Sep 19, 2023 9:45am
Novartis makes sculptures to shape knowledge of cancer symptoms
Sep 18, 2023 8:10am
FDA approves GSK's Jakafi challenger in blood cancer
Sep 15, 2023 4:16pm
AbbVie sues BeiGene over brand-new Imbruvica patent
Jun 15, 2023 10:35am
ASCO: BMS' $4B plan for Reblozyl takes shape—with one caveat
May 25, 2023 5:00pm